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Introduction: Meningitis is a serious and potentially life-threatening infection of the central nervous
system. Cryptococcus neoformans is a rare fungal cause of meningitis that commonly presents
with atypical symptoms. Although this infection is most common in immunocompromised patients,
it also occurs in immunocompetent patients. This case report describes an atypical presentation of
cryptococcal meningitis in a seemingly immunocompetent patient.
Case Report: A 40-year-old immunocompetent patient with no significant past medical history had
visited the emergency department (ED) five times within a span of 30 days reporting dental pain
and headache. Throughout each of the visits, no clear symptoms signaling the need for a meningitis
workup were observed, as the patient had been afebrile, displayed no nuchal rigidity, and his
presenting symptoms subsided within the ED after treatment. A lumbar puncture was performed
after emergency medical services brought the patient in for his sixth ED visit, initially for stroke-like
symptoms and altered mental status. Spinal fluid was indicative of cryptococcal meningitis.
Conclusion: This case highlights the challenge of identifying cryptococcal meningitis in the ED,
particularly in immunocompetent patients who do not display classic meningitis symptoms. It also
highlights the importance of keeping a broad differential and carefully ruling out diagnoses when
patients return to the ED multiple times for the same complaint. [Clin Pract Cases Emerg Med.
2021;5(4):450–454.]
Keywords: case report; immunocompetent; cryptococcal meningitis; altered mental status; headache.

INTRODUCTION
Cryptococcus neoformans (C. neoformans) mediated
meningitis is a common opportunistic infection in
immunocompromised patients, many of whom are positive
for human immunodeficiency virus (HIV).1 Other susceptible
individuals include those undergoing cancer treatment or taking
immunosuppressive medications for transplants or autoimmune
diseases. Pertinent symptoms of cryptococcal meningitis include
fever, headache, nuchal rigidity, and new onset altered mental
status. If the disease is suspected, the patient should undergo
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imaging of the brain (computed tomography or magnetic
resonance imaging) and lumbar puncture.1 The estimated number
of hospitalizations for cryptococcal meningitis in the United
States (US) is roughly 3,400 cases per year, with 700 deaths
annually in both immunocompromised and immunocompetent
individuals, indicating a rather high mortality rate.2 Almost 22%
of cryptococcal meningitis hospitalizations in the US in 2009
were in individuals without HIV.3
While the prevalence of cryptococcal meningitis in patients
with HIV within the US has been declining, cryptococcal
450
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meningitis in immunocompetent and non-HIV infected
patients has been more persistent, accounting for a substantial
proportion of all cryptococcal meningitis cases.4 Identifying the
true incidence of cryptococcal meningitis in immunocompetent
patients is challenging, since non-HIV infected patients may
have a range of levels of immunocompetence. One single-center
study stratified patients into HIV-positive, organ transplant
recipient, and non-HIV/non-organ transplant groups to better
define the immunocompetent population and showed that of
302 cryptococcal meningitis cases, 36% were from the nonHIV/non-organ transplant group, which shows that most cases
occurred in patients with a known immunocompromised status.7
Interestingly, cryptococcal meningitis has shown higher
mortality rate in non-HIV infected individuals than in HIVinfected patients in the US (13.3% and 10.5%, respectively).3
Clinical presentations can vary, and classic symptoms of
meningismus only occur in some patients. Immunocompetent
patients may have a longer time from the onset of illness to
presentation, a more evident inflammatory response (leading
to elevated intracranial pressure), and various comorbidities
that may also contribute to poor prognosis.3,5,6,7
The purpose of this case report is to illustrate how
patients with cryptococcal meningitis may not have the risk
factors, patient history, or physical exam findings that are
commonly seen in meningitis. Additionally, we emphasize that
immunocompetent patients are likely to develop cryptococcal
meningitis in the absence of a classic meningitis presentation,
thus, the disease should be considered in every patient who
presents to the emergency department (ED) with headache,
altered mental status, or behavioral change.
CASE REPORT
A 40-year-old man was brought to the ED by emergency
medical services after he was found outdoors displaying an
altered mental status, right-sided facial droop, headache, and
unsteady gait. On initial evaluation, the patient was drowsy,
following commands poorly, and could not answer questions
appropriately. His initial Glasgow Coma Scale score was 13
(eye - 3, motor - 4, verbal - 6). Provocative testing revealed
inconsistent right-sided ptosis with an otherwise non-focal
neurologic exam.
Given this presentation, there was a concern for stroke.
The patient underwent computed tomography and computed
tomography angiography of the head and neck; both were
negative for any evidence of ischemic or hemorrhagic stroke
or other abnormalities. During his continued evaluation, he
reported a headache, which he described as left temporal
pressure with associated dental pain. He reported exacerbation
of the headache with light and sound but reported not having
had any nausea or vomiting. He conveyed that his headache
was consistent with previous migraines, just more severe. He
did not report any neck stiffness, fever, or sweats. Medical
records showed that the patient had been in the ED five other
times in the past 30 days with either headache or dental pain.
Volume V, no. 4: November 2021
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What do we already know about this clinical entity?
Cryptococcal meningitis is a rare form of
fungal meningitis that is most common in
immunocompromised individuals. It often presents
with atypical symptoms and has a high mortality rate.
What makes this presentation of disease reportable?
This case of cryptococcal meningitis in a healthy
patient without any identifiable risk factors reviews
his atypical presentation, multiple visits, and the
symptom that led to diagnosis.
What is the major learning point?
Cryptococcal meningitis can occur in
immunocompetent patients. Physicians must have a
high suspicion for this disease in patients presenting
with change in behavior, and/or headaches.
How might this improve emergency medicine
practice?
Knowledge of the possible atypical presentations
of cryptococcal meningitis among physicians can
lead to earlier diagnosis, treatment, and functional
outcome in these patients.

On one visit the patient reported dental pain, was noted to
have poor dentition, and pain was improved after dental block.
On another visit the patient reported chronic headaches that
were relieved by anti-inflammatory medications. Each of these
previous assessments did not reveal any fever, neck stiffness,
or altered mental status and thus did not trigger concern for
intracranial pathology or meningitis requiring further workup.
Each time, after symptomatic improvement with medications
given in the ED, the patient was discharged and instructed to
follow up with his family medical doctor.
Later in the patient’s ED course, a family member
arrived and reported that the patient had been mentally
decompensating over the previous two weeks. The family
member stated that the patient had been acting abnormally,
including urinating, and defecating in his bedroom and
walking around the house naked. The family member was
not aware of the patient having had any recent illness, recent
travel, exposure to birds, or having pets at home. The family
member reported that the patient worked as a sandblaster and
had a sporadic history of marijuana and alcohol use. Given the
patient’s behavioral change, a lumbar puncture was performed
for further investigation.
451
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The procedure was performed in the standard fashion,
positioned in the left lateral decubitus position. The initial
opening pressure was 42 centimeters of water (cmH2O)
(reference range: 5-25 cmH2O). Analysis of cerebrospinal
fluid (CSF) from tube four revealed a red blood cell count of 5
millimeters cubed (mm3) (reference value: 0 mm3), white blood
cell count of 178 mm3 (reference range: 0-5 mm3), neutrophils
40% (reference value: 0%), lymphocytes 35% (reference range:
60%-70%), eosinophils 4% (reference value: 0%), protein
100 milligrams per deciliter (mg/dL) (reference range: 15-55
mg/dL), glucose 20 mg/dL (reference range: 40-80 mg/dL)
and lactic acid 5.4 millimoles per liter (mmol/L) (reference
range: 1.2-2.4 mmol/L). Given the concern for meningitis,
the treatment team started the patient on empiric antibiotics
(vancomycin 2 grams, ceftriaxone 2 grams, and acyclovir
710mg given parenterally) while the patient was in the ED.
The patient was admitted to the hospital where he was
followed by infectious disease specialists and given continued
empiric medications as described above. Two days after the initial
lumbar puncture, the cryptococcal CSF antigen test returned
positive. The patient was then started on amphotericin 450mg
parenterally and flucytosine 1750mg orally. Cerebrospinal fluid
and blood cultures tested positive for C. neoformans on day
three. The patient received six therapeutic lumbar punctures
during his admission for increased intracranial pressure, as
well as eventual placement of a ventriculoperitoneal shunt for
persistently elevated intracranial pressure after two months of
therapy. A fourth-generation antigen/antibody HIV enzymelinked immunosorbent assay (ELISA) test during admission was
negative. Investigation and workup for other disease processes
causing immunosuppression (including cirrhosis, autoimmune
disorders, hematologic malignancy, sarcoidosis, previous steroid
use, immunosuppressive therapy) were all negative. Further
exploration into his alcohol use noted that it was “sporadic”
and was thought to be non-contributory. Magnetic resonance
imaging done during his hospitalization revealed increased T2/
weighted-fluid-attenuated inversion recovery signal representing
ventriculitis consistent with cryptococcal meningitis (Image).
Hallucinations and odd behaviors were continually noted during
the patient’s admission, although these symptoms improved
gradually. Upon discharge from the hospital, the patient was
placed on 1600mg of oral fluconazole daily for three months
and then continued maintenance therapy of fluconazole 400mg
for 12 months. One year from the patient’s initial diagnosis
of cryptococcal meningitis, he had some improvement in
his cognition and was able to live independently, though he
continued to struggle with symptoms of headache despite
having a ventriculoperitoneal shunt and was unable to work. He
continues to follow with infectious disease to ensure continued
remission from cryptococcal meningitis.
DISCUSSION
The differential diagnosis of headaches and altered mental
status is broad and requires thoughtful consideration when
Clinical Practice and Cases in Emergency Medicine

Image. Magnetic resonance imaging without contrast. The
hyperintense areas (black arrows) in the cerebrum are increased
T2/weighted-fluid-attenuated inversion recovery signal representing
ventriculitis consistent with cryptococcal meningitis.

narrowing down the etiology of a patient’s symptoms. The
case presented here illustrates how an otherwise healthy,
immunocompetent individual may present with seemingly
mild symptoms, such as headache, before more serious
symptoms of cryptococcal meningitis develop, such as
altered mental status. Our patient’s experience highlights
the challenge of identifying cryptococcal meningitis in the
ED since individuals may not present with obvious signs of
meningismus and confirmatory diagnosis via antigen testing
takes time and is unlikely to be available while the patient is
in the emergency department.
Cryptococcal meningitis is atypical in otherwise
immunocompetent patients, with only 0.4 to 1.3 cases per
100,000 people in the United States.8 Studies have shown that
C. neoformans uses its many virulence factors and phenotypic
plasticity to avoid host macrophages after inhalation from the
environment, allowing it to bypass the blood-brain barrier and
multiply within a nutrient-depleted environment.9 There are
two leading causes of cryptococcal meningitis infection. The
first is a high level of organism exposure, such as exposure
to bird excrement where C. neoformans are found.10 The
second is immunosuppression from conditions such as HIV,
alcoholism, diabetes mellitus, or autoimmune disease.11
The current criteria used to evaluate a patient’s risk of
having cryptococcal meningitis is suboptimal. Meningismus,
a classic finding in meningitis, is defined as neck rigidity,
photophobia, and headache; however, this constellation
of symptoms occurs in less than 20% of patients with
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cryptococcal meningitis.11 Therefore, accurate diagnosis in the
ED is challenging. Most patients with cryptococcal meningitis
display at least one of the following symptoms: headache,
altered mental status, nuchal rigidity, or fever; headache being
the most commonly reported symptom.11,12 When patients
who lack the obvious risk factors for cryptococcal meningitis
present with vague symptoms or present multiple times
with the same symptoms, such as headache in the case of
our patient, the physician may mistakenly conclude that the
patient has a recurring condition and not an acute pathology.
Thus, anchoring bias is a particular barrier to swift and
accurate diagnosis of cryptococcal meningitis in otherwise
healthy, immunocompetent patients.
Management of cryptococcal meningitis after diagnosis
starts with induction therapy to quickly reach sterilization
of the CSF and normally includes intravenous combination
antifungal therapy with amphotericin B and flucytosine.13
However, this decision should be made in consultation
with an infectious disease specialist. Relieving elevated
intracranial pressure via lumbar puncture (or VP shunt)
until pressure normalizes is also an important component of
treatment for cryptococcal meningitis, due to the significant
inflammatory burden.13,14 A lumbar puncture is typically
repeated after two weeks of antifungal induction therapy to
confirm sterilization of the CSF, even among patients who
have clinically improved.13 If the CSF is sterile, therapy can
be de-escalated to a consolidation dosing range (400mg
fluconazole daily). Consolidation and maintenance therapy
with fluconazole can proceed for a year or more.11 Note that
specific recommendations vary for specific populations, such
as HIV-infected individuals, organ transplant recipients,
children, and pregnant women.14 A comprehensive treatment
of cryptococcal meningitis management for ED clinicians can
be found in Fisher et al. 5
Patients with cryptococcal meningitis who are not
presenting with classic signs and symptoms of meningitis and
who do not have the main risk factors (immunosuppression),
often have poor outcomes because diagnosis and treatment
are delayed.11 The most important prognostic factors are
the nature of the underlying immunosuppression and the
concurrent disease processes. Other factors conferring poor
prognosis include positive India ink examination of the CSF,
CSF white blood cell count less than 20 µL, initial CSF or
serum cryptococcal antigen titer greater than 1:32, and high
opening pressure on lumbar puncture.15
CONCLUSION
Overall, C. neoformans meningitis is a rare cause of
meningitis in immunocompetent individuals; however, it
is still important to consider in patients with headache and
altered mental status given its insidious onset and high
mortality rate. A careful and detailed history is warranted for
every encounter to evaluate risk factors for serious diseases
and narrow the differential diagnoses. Furthermore, when
Volume V, no. 4: November 2021

a patient presents multiple times to the ED with symptoms
like headache, it is imperative that clinicians reconsider
the differential diagnosis, initiate immediate testing for
meningitis-causing microorganisms and begin appropriate
supportive care.
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